Erasca

About:

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Website: https://www.erasca.com/

Twitter/X: erasca

Top Investors: Andreessen Horowitz, OrbiMed, Cormorant Asset Management, EDBI, Invus

Description:

Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery programs for undisclosed targets that are biological drivers of cancer and are pursuing additional opportunities for pipeline expansion through academic and biopharmaceutical collaborations, providing patients with new potential solutions to not just treat but cure cancer. Erasca was founded in 2018 and is headquartered in San Diego, California.

Total Funding Amount:

$629M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)erasca.com

Founders:

Jonathan Lim

Number of Employees:

101-250

Last Funding Date:

2024-05-16

IPO Status:

Public

© 2025 bioDAO.ai